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Abstract
During viral infections cellular gene expression is subject to rapid alterations induced by both viral and antiviral
mechanisms. In this study, we applied metabolic labeling of newly transcribed RNA with 4-thiouridine (4sU-tagging) to
dissect the real-time kinetics of cellular and viral transcriptional activity during lytic murine cytomegalovirus (MCMV)
infection. Microarray profiling on newly transcribed RNA obtained at different times during the first six hours of MCMV
infection revealed discrete functional clusters of cellular genes regulated with distinct kinetics at surprising temporal
resolution. Immediately upon virus entry, a cluster of NF-kB- and interferon-regulated genes was induced. Rapid viral
counter-regulation of this coincided with a very transient DNA-damage response, followed by a delayed ER-stress response.
Rapid counter-regulation of all three clusters indicated the involvement of novel viral regulators targeting these pathways.
In addition, down-regulation of two clusters involved in cell-differentiation (rapid repression) and cell-cycle (delayed
repression) was observed. Promoter analysis revealed all five clusters to be associated with distinct transcription factors, of
which NF-kB and c-Myc were validated to precisely match the respective transcriptional changes observed in newly
transcribed RNA. 4sU-tagging also allowed us to study the real-time kinetics of viral gene expression in the absence of any
interfering virion-associated-RNA. Both qRT-PCR and next-generation sequencing demonstrated a sharp peak of viral gene
expression during the first two hours of infection including transcription of immediate-early, early and even well
characterized late genes. Interestingly, this was subject to rapid gene silencing by 5–6 hours post infection. Despite the
rapid increase in viral DNA load during viral DNA replication, transcriptional activity of some viral genes remained
remarkably constant until late-stage infection, or was subject to further continuous decline. In summary, this study pioneers
real-time transcriptional analysis during a lytic herpesvirus infection and highlights numerous novel regulatory aspects of
virus-host-cell interaction.
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Introduction
Herpesviruses are large DNA viruses which cause a broad range
of disease ranging from the common cold sore to cancer. They all
share the ability to establish a life-long, latent infection, leaving the
infected individual at constant risk of reactivation and subsequent
disease. The human cytomegalovirus (HCMV) poses a severe
threat to immunocompromised patients and represents the most
common infective cause of congenital disorders affecting about 1
in 1,000 newborns [1]. Like all herpesviruses, cytomegaloviruses
(CMV) have co-evolved with their animal and human hosts for
millions of years. During this time, they have mastered host-cell
modulation to facilitate their needs and thus provide ideal tools to
study many fundamental cellular processes.
Numerous signaling events are triggered during the first few
hours of infection. As such, binding of CMV particles to the cell
membrane and virus entry result in the activation of cellular
signaling pathways, some of which, e.g. NF-kB signaling, play an
important role in initiating lytic viral infection [2–4]. Concomi-
tantly, viral pathogen-associated molecular patterns are recog-
nized by pattern-recognition receptors, resulting in robust
activation of an innate immune response. Virion-associated
proteins as well as the advent of viral gene expression then
counteract intrinsic and arising host cell defense [5]. Several high-
throughput studies addressed the transcriptional response of the
cell to lytic CMV infection by analyzing temporal changes in total
RNA levels [3,6–10]. These studies revealed lytic CMV infection
altered the expression of numerous cellular genes involved in a
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variety of processes including inflammation, innate immunity, cell
cycle progression, cellular metabolism and cell adhesion.
One of the earliest events upon entry of the viral DNA into the
nucleus is the deposition of viral genomes at nuclear domain
(ND10) bodies [11,12]. This appears to be part of an intrinsic
antiviral defense mechanism suppressing the expression of foreign
DNA entering the nucleus [13]. In part, this is mediated by
chromatin-remodeling enzymes recruited to these structures [14–
16]. In HCMV infection, this intrinsic host defense is overcome by
the viral tegument protein pp71 [17,18] as well as the viral
immediate early 1 (IE1) protein [19,20]. In lytic murine
cytomegalovirus (MCMV) infection, dispersion of ND10 bodies
seems to be predominately mediated by the IE1 protein [21]
(reviewed in [22]). In addition to disruption of ND10 body-
mediated antiviral defense, the immediate-early proteins initiate
the lytic replication cycle by facilitating the transcription of early
genes [23,24]. The latter then modulate host cell environment,
disarm the arising immune response, and establish the viral
replication machinery. Upon viral DNA replication, viral late gene
expression is initiated, culminating in the production and release
of infectious virus particles [25].
The analysis of de novo early viral gene expression has been
substantially hindered by large amounts of so called ‘virion-
associated RNA’, unspecifically bound by the virus particles and
delivered to the newly infected cell [26–30]. Chromatin immuno-
precipitation (ChIP) has thus been employed to study the kinetics
of viral transcriptional activity by looking at markers of active and
inactive chromatin associated with the viral promoters. Immedi-
ately upon infection of permissive fibroblasts (at ‘pre-IE’ times of
infection, using low multiplicities of infection) HCMV genomes
become associated with markers of repressed chromatin [31]. As
infection progresses, the chromatin status of viral promoters
reflects the cascade of viral immediate-early, early and late gene
expression [32,33].
Standard gene expression analysis (using total RNA) to study
kinetics of transcriptional regulation has several limitations. Firstly,
short-term changes in total RNA levels do not match changes in
transcription rates but are inherently dependent on the RNA half-
life of the respective transcripts [34]. This strongly favors the
detection of up-regulation of short-lived transcripts, commonly
encoding for transcription factors and genes with regulatory
function. This, in turn, may result in substantial bias in
downstream bioinformatics analyses. Secondly, the temporal
resolution - particularly for down-regulated genes - is rather low
due to the relatively long median RNA half-life (5–10 h) in
mammalian cells [35,36]. The same is true for detecting (viral)
counter-regulation of cellular genes induced earlier in infection.
Thirdly, alterations in RNA synthesis rates cannot be differenti-
ated from changes in RNA decay rates. Finally, transcriptional
activity of the incoming CMV genomes cannot be definitively
studied due to the presence of virion-associated RNA introduced
to the newly infected cells by the incoming virus particles [28,37].
Recently, we developed an approach termed 4-thiouridine-
(4sU)-tagging to purify newly transcribed RNA from total cellular
RNA [34]. This is applicable to a broad range of organisms
including vertebrates, drosophila and yeast [38,39]. In short, cells
are cultured in presence of 4sU resulting in metabolic thiol-
labeling of newly transcribed RNA at a frequency of about one
4sU residue in 50 to 100 nucleotides [34]. After isolation of total
cellular RNA, RNA-incorporated 4sU is thiol-specifically biotiny-
lated. Labeled newly transcribed RNA is then efficiently purified
from total RNA using streptavidin-coated magnetic beads. All
three RNA fractions, i.e. total, newly transcribed and unlabeled
pre-existing RNA, are suitable for quantitative RT-PCR (qRT-
PCR), microarray analysis and next-generation sequencing
[34,40–43]. In the present study, we employed this approach to
lytic murine cytomegalovirus (MCMV) infection of fibroblasts to
study the real-time kinetics of cellular and viral gene expression
using qRT-PCR, microarray analysis and RNA-sequencing
(RNA-seq). We show that this approach circumvents all the
caveats mentioned above, thereby providing intriguing new
insights into cytomegalovirus host-cell modulation and regulation
of viral gene expression.
Results
Establishment of 4sU-tagging for lytic MCMV infection
Upon its addition to the cell culture medium, 4-thiouridine
(4sU) is rapidly taken up by cells, phosphorylated and incorporated
into newly transcribed RNA in a concentration-dependent
manner [34]. To establish 4sU-tagging for MCMV infection, we
first analyzed the effect of lytic MCMV infection on 4sU-
incorporation. NIH-3T3 fibroblasts were infected with MCMV
at a multiplicity of infection (MOI) of 10. At different times of
infection, 200 mM 4sU was added to the cell culture medium for
1 h. Total RNA was prepared and subjected to thiol-specific
biotinylation. 4sU-(biotin)-incorporation was quantified by dot blot
(Figure 1A). At all times of infection, 4sU-incorporation was at
least as efficient as in uninfected cells, ensuring efficient
purification of newly transcribed RNA at all times of infection.
Interestingly, from 5 to 24 hours post infection (hpi) the extent of
4sU-incorporation into cellular RNA was about 20-fold greater
than in uninfected cells. By 47–48 hpi this had returned to levels
found in uninfected cells. These data are consistent with increased
transcriptional activity as well as enhanced nucleoside metabolism
during lytic CMV infection [44].
Metabolic labeling of newly transcribed RNA with 4sU has
negligible polar effects on eukaryotic cells [34,45,46]. To exclude
Author Summary
Cytomegaloviruses are large DNA viruses, which establish
life-long latent infections, leaving the infected individual at
risk of reactivation and disease. Here, we applied 4-
thiouridine-(4sU)-tagging of newly transcribed RNA to
monitor the real-time kinetics of transcriptional activity of
both cellular and viral genes during lytic murine CMV
(MCMV) infection. We observed a cascade of MCMV-
induced signaling events including a rapid inflammatory/
interferon-response, a transient DNA-damage-response
and a delayed ER-stress-response. All of these were heavily
counter-regulated by viral gene expression. Besides dra-
matically increasing temporal resolution, our approach
provides the unique opportunity to study viral transcrip-
tional activity in absence of any interfering virion-associ-
ated-RNA. Virion-associated-RNA consists of transcripts
that are unspecifically incorporated into the virus particles
thereby resembling the cellular RNA profile of late stage
infection. A clear picture of which viral genes are
expressed, particularly at very early times of infection,
could thus not be obtained. By overcoming this problem,
we provide intriguing insights into the regulation of viral
gene expression, namely 1) a peak of viral gene expression
during the first two hours of infection including the
expression of well-characterized late genes and 2) remark-
ably constant or even continuously declining expression of
some viral genes despite the onset of rapid viral DNA
replication.
Real-time RNA Profiling of Lytic MCMV Infection
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gross adverse effects of 4sU-labeling on MCMV replication, we
applied 1 h of 200 mM 4sU-treatment to NIH-3T3 cells at
different times of infection. No effect of 4sU exposure on virus
titers, determined at 48 hpi, was observed (Figure S1). We
therefore decided to use 1 h of 200 mM 4sU in all following
experiments.
Kinetics of transcriptional activity of cellular genes during
early MCMV infection
To detail transcriptional changes in host gene expression during
early MCMV infection, we infected NIH-3T3 fibroblasts with
MCMV at an MOI of 10 and labeled newly transcribed RNA
from 1–2, 3–4 and 5–6 hpi. Three replicates of both total and
newly transcribed RNA were subjected to Affymetrix Gene ST 1.0
arrays. After Robust Multichip Average (RMA) normalization, we
identified all genes significantly regulated (p#0.05) by at least 2-
fold compared to uninfected cells in any condition. This resulted in
the identification of 1,674 probe sets showing differential
expression (Table S1a). With the exception of 4 genes, all
differentially expressed genes were either exclusively up- or
down-regulated during the first 6 h of infection. The number of
genes with differential expression detectable in total RNA only
represented 13% (at 2 hpi), 25% (at 4 hpi) and 54% (at 6 hpi) of
those identified in newly transcribed RNA. As predicted, down-
regulation only started to become detectable in total RNA with
substantial delay, i.e. at 4 hpi (Figure 1B). Furthermore, a peak of
MCMV-induced and rapidly counter-regulated gene expression
was apparent in newly transcribed RNA at 3–4 hpi. This was
invisible in total RNA. The overlap of differential gene expression
detectable at different times of infection was substantially greater
for newly transcribed RNA (Figure 1C). Notably, we found all
genes induced or repressed by at least 2-fold in total RNA at 6 hpi
to show concordant regulation in newly transcribed RNA
(Figure 1D). In addition, only 3 probe sets showed more than 2-
fold greater regulation in total RNA than in newly transcribed
RNA (genes listed in Table S1b). Hence, the vast majority of
differential gene expression during the first six hours of MCMV
infection is the result of alterations in transcription rates and not
due to changes in RNA decay rates. We therefore decided to focus
all our subsequent analyses on newly transcribed RNA.
4sU-tagging details discrete functional gene clusters
regulated with distinct kinetics
Clustering genes based on .2-fold differences in regulation at
different times of infection, we identified 5 clusters of genes
characterized by distinct kinetic profiles (Figure 2A; for details and
genes represented in each cluster see Table S1c and materials and
methods). MCMV-induced genes peaked at 1–2 (Cluster 1), 3–4
(Cluster 2) or 5–6 hpi (Cluster 3). Of these, Cluster 2 was not
detectable in total cellular RNA at all. Rapid and rather constant
down-regulation was characteristic of genes in Cluster 4, while
genes in Cluster 5 showed delayed down-regulation. These five
clusters also became apparent when unsupervised clustering based
on the changes in induction between 1–2, 3–4 and 5–6 hpi was
performed (see Figure S2). To look for functional characteristics of
these five gene clusters, we performed an enrichment analysis of
Gene Ontology (GO) terms (biological process) and KEGG
pathways. Interestingly, all five clusters were associated with
distinct functional terms (see Figure 2B; for complete list of over-
represented gene ontologies see Table S2a). Genes in Cluster 1
Figure 1. Establishment of 4sU-tagging for lytic MCMV infection. (A) Incorporation of 4sU throughout MCMV infection. Cells were infected
with MCMV at an MOI of 10 and exposed to 200 mM 4sU for 1 h at different times of infection before total RNA was isolated. Thiol-specifically
biotinylated RNA was subjected to dot blot analysis in 10-fold dilutions (1 mg down to 1 ng). A biotinylated oligonucleotide of 81 nt (PC, 100 ng
down to 0.1 ng) was used to quantify 4sU-incorporation; M=mock control. (B)–(D) Comparison of genes identified to be regulated in newly
transcribed RNA to genes regulated in total RNA. (B) Numbers of genes up- and down-regulated (.2-fold, p#0.05) at different times of infection are
shown for newly transcribed RNA and total RNA. (C) Venn diagrams of all genes regulated more then 2-fold in newly transcribed RNA and total RNA.
(D) Venn diagrams showing genes regulated .2-fold in total RNA at 2, 4 and 6 hpi and in newly transcribed RNA at and prior to the indicated time
point of infection; red =newly transcribed RNA, blue= total RNA.
doi:10.1371/journal.ppat.1002908.g001
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Figure 2. Gene expression kinetics define distinct functional clusters. (A) Heat-maps indicating the fold-changes are shown as matrices with
rows representing genes and columns representing the time points post infection. Red represents up-regulation, blue down-regulation (.2-fold,
p#0.01) in newly transcribed RNA relative to uninfected cells. Ordering of genes in the heat-maps was determined using non-supervised hierarchical
Real-time RNA Profiling of Lytic MCMV Infection
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were involved in immune and inflammatory processes as well as
apoptosis. Genes in Cluster 2 mainly played a role in p53 signaling
and cell cycle progression. Delayed induction was observed for
genes involved in the ER stress response (Cluster 3). Rapid and
sustained down-regulation was observed for genes involved in cell
proliferation and differentiation, focal adhesion as well as actin
filament-based processes (Cluster 4). Finally, delayed down-
regulation was characteristic of genes with a role in chromatin
assembly and cell cycle processes (Cluster 5). Due to the delayed
visibility of down-regulation in total RNA (see Figure 1B), Cluster
4 and 5 could only be differentiated using newly transcribed RNA.
This approach thus allowed dissecting differential gene expression
into discrete functional clusters regulated with distinct kinetics.
These provided us with ideal templates to elucidate the underlying
transcription factors and molecular mechanisms using in silico
promoter analysis.
Promoter analysis associates distinct transcription factors
with each individual gene cluster
We performed promoter analysis on the five clusters to identify
cellular transcription factors (TFs) involved in their regulation.
Proximal promoter regions (PPR) ranging from 2500 to +100 bp
from the transcription start site (TSS) were analyzed for over-
represented transcription factor binding motifs. While a number of
transcription factor binding motifs were over-represented in the
five clusters (for complete list and data see Table S2b), we observed
distinct transcription factor binding sites to be uniquely over-
represented in each of the individual clusters (see Figure 2C for
exemplary TFs and Table S2b). These correlated very well with
the functional annotations of the associated clusters. In Cluster 1,
uniquely over-represented binding sites were found for NF-kB and
IRF-1. NF- kB is one of the key players of the cellular immune
response and it thus has important roles in the antiviral defense
[47]. Infection with CMV results in an activation of this
transcription factor [48], however, subsequently it is counter-
regulated by the virus. In the case of MCMV this is mediated by
the viral protein M45 [49,50]. IRF-1 is an important factor in the
antiviral IFN response and, like canonical type I interferon
signaling, results in activation of promoters containing interferon
stimulated response elements (ISREs). HCMV pp65 can inhibit
activity of IRF-1 [51]. In addition, the MCMV M27 counteracts
the interferon response by targeting Stat2 for degradation [52].
Elk-1 and YY1 are examples of transcription factors for which
binding sites were over-represented in the cluster of genes (Cluster
2) showing a peak of induction at 3–4 hpi. Elk-1 is activated by the
MAPK/ERK pathway, which is stimulated during HCMV
infection [53]. YY1 is a DNA-binding transcription factor that
acts as a repressor of some promoters and an activator of others
[54]. It has been shown that YY1 can directly bind to the HCMV
major IE promoter region and mediates repression of HCMV IE
gene expression [55]. In latent MCMV infection, YY1 is also
specifically recruited to the major immediate early protein (MIEP)
promoter and might thus play a role in the control of latency and
reactivation [56].
For Cluster 3, which contained genes induced with delayed
kinetics (Figure 3C), we found over-represented binding sites for c-
Myc and Ap-4. c-Myc is a proto-oncogene which drives cell cycle
progression and apoptosis, whereas cellular differentiation and cell
adhesion are negatively influenced [57]. Both, IE1 and IE2
proteins of HCMV were shown to be able to up regulate the c-
Myc promoter and thus to increase c-Myc expression [58]. AP-4
was identified to be a direct transcriptional target of c-Myc [59].
In Cluster 4, genes had uniquely over-represented binding sites
for Mzf1 and AP2. Mzf1 belongs to the Kru¨ppel family of zinc
finger proteins and plays a role in regulating transcriptional events
during hemopoietic development and controls cell proliferation as
well as tumorigenesis [60,61]. Until now, nothing is known about a
role of Mzf1 upon CMV infection. AP2 are a family of
transcription factors which were shown to play role in apoptosis,
cell-cycle control and proliferation as well as tumorigenesis [62].
Little is known about a role of AP2 in CMV infection.
Cluster 5 showed uniquely over-represented binding sites for
E2F and C/EBP. E2F is a family of TFs which are involved in the
regulation of S phase genes as well as DNA damage and apoptosis
[63]. For E2F-1, Song and Stinski showed that HCMV increases
its activity [64]. C/EBP belongs to the bZIP transcription factors
and has important function in adipocyte differentiation, maintains
energy homeostasis and regulates cell differentiation [65]. It can
induce growth arrest by interacting with CDK2 and CDK4 and
interacts with the heterodimer E2F-DP to inhibit cell growth
[66,67]. To date, little is known about its function in CMV
infection, however, the MIEP promoter of CMV contains a
binding site for this transcription factor [68].
Two exemplary TFs were chosen for further validation. As a
proof-of-principle TF, we decided to look at NF-kB to see whether
it’s well-described rapid induction and counter-regulation during
CMV infection [48,49] would precisely reflect the transcriptional
changes we observed in newly transcribed RNA under our
experimental conditions. NF-kB-dimers of the NF-kB- (p105 and
p100) and Rel-subfamily (c-Rel, RelB and RelA) are present in
inactive IkB-bound complexes in the cytoplasm. IkK-mediated
phosphorylation induces degradation of the inhibitor IkBa,
enabling translocation of the NF-kB dimers to the nucleus and
enhanced transcription of NF-kB target genes (reviewed in [69]).
To look for degradation of the inhibitor IkBaduring the first 12 h
of MCMV infection, we performed immunoblotting (Figure 3A).
In addition, immunofluorescence analysis was performed to reveal
the shift of RelA into the nucleus (Figure 3B). Results from both
experiments demonstrated the kinetics of transcriptional regula-
tion of genes in Cluster 1 to precisely mirror NF-kB activation,
highlighting the ability of 4sU-tagging to detail real-time
transcription factor activity.
In addition, we looked at a representative TF of Cluster 3,
namely c-Myc. c-Myc forms a heterodimer with Max, followed by
its binding to target genes [70]. Furthermore, phosphorylation of
two amino acids at the NH2-terminal domain is important for
transactivation of c-Myc [71]. Hagemeier et al. showed that
HCMV IE1 and IE2 can transactivate the c-Myc promoter [58].
We performed luciferase assays using a c-Myc-specific reporter
clustering. Shown are the 5 clusters of genes we identified. (B) All clusters are associated with distinct functional annotations. Enrichment analysis
results of Gene Ontology ‘Biological Process’ terms and KEGG pathways are shown for each of the five clusters with the most significant (p#0.01)
categories displayed in the graphs as bars, sorted from bottom (most significant) to top. To reduce redundancy, similar terms are represented by the
most significant and specific term. For complete list of functional annotations see Table S2a. (C) Specific transcription factor binding sites correlate
with functional clusters. Shown are exemplary transcription factors with over-represented binding sites unique for the different clusters. For a
complete list of over-represented transcription factor weight matrices see Table S2b. Illustrated are the transcription factor weight matrices, the
percentage of promoters with sites and p-value.
doi:10.1371/journal.ppat.1002908.g002
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construct transfected into NIH-3T3 cells 48 h prior to infection to
analyze c-Myc activation. Luciferase activity started to significant-
ly increase at 4 hpi, matching the expression kinetics of genes in
Cluster 3 (Figure 3C).
Virus-mediated regulation and counter-regulation of
host gene expression
We then addressed the role of viral gene expression in the
regulation of each cluster using infection with UV-inactivated
virus. To provide a more comprehensive picture, we extended the
kinetics until 48 hpi. To this end, NIH-3T3 cells were infected
with either wild-type (wt) or UV-inactivated virus. RNA was
labeled for 1 h at different times of infection and newly transcribed
RNA was purified. Transcription rates of exemplary genes of each
functional cluster were determined in newly transcribed RNA
using quantitative RT-PCR (qRT-PCR). This included NF-kB-
(Cluster 1), interferon- (Cluster 1), DNA-damage- (Cluster 2) and
ER-stress- (Cluster 3) induced genes as well as MCMV-repressed
genes involved in the regulation of cell differentiation (Cluster 4)
and cell cycle/chromatin organization (Cluster 5). The house-
keeping gene Lbr (Lamin B receptor) was used for normalization.
Cluster 1 contains both NF-kB- as well as interferon-induced
genes. We thus chose NF-kBia (NF-kB-inhibitor alpha), an NF-
kB-induced negative regulator of the NF-kB response, as well as
Ifit1 (Interferon-induced protein with tetratricopeptide repeats 1)
for this analysis. Both NF-kBia and Ifit1 were rapidly induced and
counter-regulated by lytic MCMV infection (Figure 4A, B).
Induction of both genes following infection with UV-inactivated
virus was comparable to wt-MCMV infection, consistent with
previous reports showing that viral gene expression is not required
for induction of both NF-kB- and interferon-signaling. In both
cases, however, counter-regulation was substantially delayed
following infection with UV-inactivated virus. While counter-
regulation of the NF-kB response is consistent with the MCMV
M45 gene product efficiently targeting NF-kB- signaling [50], a
viral gene product targeting the induction of the interferon
response remains to be identified [72].
To monitor DNA-damage response-mediated signaling, we
analyzed transcriptional activity of Gadd45a (Growth arrest and
DNA damage-inducible protein A), a well characterized DNA
damage- induced gene [73]. Consistent with our microarray data,
qRT-PCR revealed the same slightly delayed induction at 3–4 hpi,
followed by a more protracted counter-regulation than we
observed for NF-kBia and Ifit1. Interestingly, UV-inactivated
virus also triggered the induction of Gadd45a with similar kinetics.
This was, however, no longer counter-regulated, but continued to
increase until 48 hpi (Figure 4C). For HCMV it has been
described that IE1 increases p53 activity by phosphorylation
through ATM, an important kinase in the DNA damage response
[74]. While our data are indicative of counter-regulation of this
response by an MCMV gene product, we cannot exclude that the
induction and the enhanced response - at least in parts - reflects
increased activation by the UV-damaged viral DNA.
For Cluster 3, expression of Herpud1 (Homocysteine-responsive
endoplasmic reticulum-resident ubiquitin-like domain member 1
protein), a gene induced by endoplasmatic reticulum (ER) stress
[75], was monitored. Delayed induction was observed, which was
rapidly counter-regulated. Induction of Herpud1 was lost upon
infection with UV-inactivated virus, consistent with viral gene
expression being required for the induction of the ER stress
response. In summary, these findings indicate that a so far
unknown viral gene product counteracts the ER stress response
provoked by viral gene expression (Figure 4D). For HCMV, this
function is thought to be performed by the viral pUL38 protein
[76].
For Clusters 4 and 5 we chose to monitor the transcription
kinetics of Lamb1-1 (Laminin beta 1), an important extracellular
Figure 3. Validation of exemplary transcription factors. NIH-3T3 fibroblasts were infected with MCMV at an MOI of 10 for the indicated time
points and lysates were prepared for western blot analysis (A), for immune staining (B) or luciferase assay (C). Western blot analysis was performed
on samples prepared from uninfected and infected NIH-3T3 cells probed for RelA and IkBa (A). GAPDH was probed as loading control. For the
immunofluorescence staining (B) cells were fixed and stained with the indicated antibodies; white circle indicating nucleus, nuclear dimensions were
acquired by DAPI staining and its outline was overlaid into the shown channels; green, RelA; red, viral IE1. For the luciferase assays cells were
transfected with a c-Myc-reporter construct (C) and infected 48 hours post transfection with MCMV at an MOI of 10. At the indicated times post
infection, Firefly-Luciferase measurements were performed in triplicates. Shown is the mean +/2 SD of a representative of three experiment;
mpi =minutes post infection, hpi = hours post infection.
doi:10.1371/journal.ppat.1002908.g003
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matrix glycoprotein, and Top2a (Topoisomerase 2 alpha), which is
involved in the control and alteration of the topologic states of
DNA during transcription [77,78]. Interestingly, consistent down-
regulation of both genes was observed following wt-MCMV, but
not UV-MCMV infection, indicating that viral gene expression is
required for both their regulation (Figure 4 E, F).
In summary, these data highlight that all cellular signaling
pathways we identified to be induced during early MCMV
infection are rapidly counter-regulated by the virus later on. In
contrast, down-regulation of defined cellular signaling pathways
prevails and thus most likely represents an intentional action of the
virus to facilitate its needs.
Analysis of newly transcribed RNA allows studying viral
gene expression in absence of virion-associated RNA
Herpesvirus particles, like other herpesviruses, unspecifically
incorporate and transfer large amounts of so called ‘virion-
associated RNA’ to newly infected cells [26–30,37]. This has
substantially hindered detailed studies on the kinetics of viral gene
expression during the first few hours of infection and in latency.
4sU-tagging allows the removal of virion-associated RNA and
thus, the dissection of the regulation of viral gene expression
during the initial phase of infection. To show that 4sU-tagged
newly transcribed RNA fraction is indeed free of virion-associated
RNA, we labeled newly transcribed RNA in MCMV infected
NIH-3T3 cells from 1–2, 3–4 and 7–8 hpi in the presence and
absence of the RNA polymerase II inhibitor Actinomycin D (Act-
D). Act-D treatment inhibits RNA synthesis and thus prevents
4sU-incorporation into newly transcribed RNA. Following
isolation of total RNA, we included a DNase digest prior to
biotinylation to further remove viral DNA. Newly transcribed
and total RNA samples were subjected to qRT-PCR analysis for
the spliced viral ie1 gene and the cellular housekeeping gene Lbr.
In total RNA, ie1 transcripts were detectable even in presence of
Act-D, consistent with large amounts of virion-associated RNA
delivered to the infected cells. However, in newly transcribed
RNA virtually no ie1 and Lbr transcripts (below detection limit of
our qRT-PCR assay) were detectable in presence of Act-D,
consistent with the complete removal of virion-associated RNA
(Figure 5A).
Figure 4. Identification of virus-specific regulation and counter-regulation using UV-inactivated virus. Quantitative RT-PCR was
employed to measure transcription rates of exemplary genes of the five gene clusters (A–F). NIH-3T3 were infected with wild-type (wt) or UV-
inactivated (1500 J, 15 min) MCMV (MOI of 10) for the indicated time points. Displayed are the fold-changes relative to uninfected cells normalized to
Lbr. Fold-changes in between 0.5- and 2-fold were considered as non-regulated. Shown are the combined data (means +/2 SD) of three independent
experiments.
doi:10.1371/journal.ppat.1002908.g004
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Figure 5. Real-time kinetics of viral gene expression. (A) 4sU-tagging allows efficient removal of viral DNA and virion-associated RNA. Newly
transcribed RNA was labeled with 200 mM 4sU for 1 h in MCMV-infected NIH-3T3 cells at 21 to 0 (mock), 1–2, 3–4 and 7–8 hpi. As a negative control,
Actinomycin-D was added to cells prior to infection to block transcription and thus 4sU-incorporation. Total RNA was isolated, treated with DNaseI and
newly transcribed RNA was purified. qRT-PCR analysis was performed on newly transcribed RNA for viral ie1 and cellular Lbr. Shown are the combined
data (means +/2 SD) of three independent experiments. (B–F) Gene expression kinetics of exemplary viral genes. Shown are qRT-PCR measurements of
newly transcribed RNA for ie1 (B), the early genes m169 (C) and m152 (D) as well as for the late genes m129/131 (E) and M94 (F). Synthesis rates were
normalized to Lbr expression. Shown are the combined data (means +/2 SD) of three independent experiments. (G) Contribution of viral transcripts to
all coding sequence reads (CDS). RNA-seq was performed on newly transcribed, total and unlabeled pre-existing RNA samples (n=1). Reads were
mapped to both the cellular and viral transcriptome/genome. The contribution of viral reads to all CDS reads at different times of infection is shown.
doi:10.1371/journal.ppat.1002908.g005
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4sU-tagging reveals a peak of viral gene expression at 1–
2 hpi, including immediate-early, early and even late
gene expression
We then performed a comprehensive time-course analysis of
transcriptional activity during lytic MCMV infection. To study
relevant time frames, we first determined the kinetics of viral
DNA replication in NIH-3T3 cells infected with wt-MCMV at an
MOI of 10. Both qRT-PCR on M54, the catalytic subunit of
MCMV DNA polymerase, and southern blot analysis of
concatameric DNA revealed viral DNA replication to start at
,15 hpi (Figure S3). We therefore decided to label newly
transcribed RNA at 1–2 hpi, 3–4 hpi, 5–6 hpi, 11–12 hpi (prior
to the onset of DNA replication), 24–25 hpi (first infectious virus
particles starting to be released) and at 47–48 hpi (late stage
infection). Following DNase digest and purification of newly
transcribed RNA, this was subjected to qRT-PCR analysis for ie1
as well as two genes well characterized to be expressed with either
early (m152 and m169) or late (m129/131 and M94) kinetics
[79–81]. For the spliced late gene m129/m131 [82] we designed
the qRT-PCR to span exon-exon junctions to further eliminate
any residual risk of amplifying viral DNA or transcripts derived
from the opposite DNA strand. To our great surprise, we found
not only the two early, but also the two late genes to be well
expressed during the first few hours of infection peaking at 1–2
hpi followed by a down-regulation at 5–6 hpi (Figure 5B–F). It is
important to note that we could not detect any specific signals in
any assay when qRT-PCR was carried out using non-reverse-
transcribed samples or Act-D-treated samples (data not shown).
This demonstrated the complete removal of viral DNA and
virion-associated RNA from these samples. Expression of M94
was also observed when strand-specific cDNA synthesis was
performed, matching the kinetics shown in Figure 5F (data not
shown). In addition, agarose electrophoresis on m129/m131-
PCR products confirmed a band of the predicted size, thereby
excluding amplification of viral DNA or a transcript expressed
from the opposite DNA strand (data not shown). Interestingly,
qRT-PCR analysis on total RNA also revealed a transient, less
prominent peak in viral transcript levels at 2 hpi for ie1 and m152
and at 4 hpi for m169 and m129/m131 (Figure S4). For ie1,
Actinomycin-D treatment demonstrated that virion-associated
RNA only comprised ,5% of total RNA levels at 1–2 hpi
(Figure 5A). Similar data were obtained for m152 (data not
shown). Therefore, there appears to be at least a fraction of newly
synthesized viral transcripts which are rather unstable (RNA half-
life of ,1 to 4 h).
A second unexpected finding was the dramatic drop of
transcriptional activity of all viral genes starting 3–4 hpi. For
ie1 and m169, transcription dropped .30-fold by 5–6 hpi
(compared to 1–2 hpi) and then leveled off (Figure 5B, C). In
contrast, transcription rates of m152 continued to drop exceeding
500-fold at 47–48 hpi (Figure 5D). Both late genes, i.e. m129/
m131 and M94, showed a substantial increase in synthesis rates
with the onset of viral DNA replication, consistent with their
kinetic class. To rule out that our observations were simply
caused by the high MOI, we repeated the experiment using a low
MOI of 0.5 (Figure S5). As observed with high MOI, ie1
transcription had already peaked by 1–2 hpi. In contrast,
transcription rates of both the two early and late genes had not
peaked and were now peaking at 3–4 hpi (see Figure S5).
Nevertheless, transcription rates of all five genes significantly
dropped by 5–6 hpi. These data indicate that transient expression
of viral late genes during the first few hours of infection is not an
artifact of high MOI.
RNA-seq reveals rapid silencing of viral gene expression
after the initiation of early gene expression
To confirm these observations at the whole transcriptome level,
we repeated the experiment described above and subjected newly
transcribed RNA samples from 7 time points (mock, 1–2, 5–6, 11–
12, 18–19, 24–25 and 47–48 hpi) to next-generation sequencing.
In addition, we included samples of total and pre-existing RNA
(mock, 25 hpi and 48 hpi). We obtained between 16 and 42 million
reads per sample, which were mapped to the mouse transcrip-
tome, mouse genome, MCMV predicted coding sequences and
the MCMV genome in the respective order (for details on read
numbers and mapping statistics see Table S4a). As expected,
introns were substantially over-represented in newly transcribed
RNA (Figure S6 and Table S4a) reflecting the substantially greater
contribution of immature, unspliced nascent transcripts [41,43].
When considering only coding sequences, viral transcripts
accounted for ,20% of all reads in total RNA at 48 hpi and in
newly transcribed RNA at 47–48 hpi (Figure 5G). Interestingly,
the extent of viral gene expression in newly transcribed RNA at 1–
2 hpi also accounted for ,15% of all reads, dropping to around
5% of all reads at 5–6 hpi. This corroborates our qRT-PCR
finding of a burst of viral gene expression at 1–2 hpi, but also
highlights that not all viral genes expressed at 1–2 hpi are subject
to the same massive down-regulation we observed for m152. A
closer look at the distribution of transcription rates across the
whole viral genome (direct and complementary strand) revealed
viral gene expression arising from multiple loci at 1–2 hpi
(Figure 6). By 5–6 hpi, transcription rates of many, but not all,
viral genes dropped substantially (for details see Table S4b). With
the onset of viral DNA replication, late gene expression was
initiated, accounting for the increasing number of viral reads at
24–25 and 47–48 hpi (although of shifted viral gene subsets
compared to 1–2 hpi). At late stages of infection, transcription
rates of viral genes stabilized, reflected by the continuous
accumulation of the respective viral transcripts in both total and
unlabeled pre-existing RNA (Figure S7).
Discussion
In this work, we first employed 4sU-tagging combined with
microarray analysis to study the dynamic changes in transcrip-
tional activity of NIH-3T3 fibroblasts during early MCMV
infection. Interestingly, we found virtually all changes in total
cellular RNA to be matched by concordant changes in newly
transcribed RNA, indicating that alterations in RNA decay rates
do not substantially contribute to differential gene expression
during early phase of MCMV infection of fibroblasts. This is
consistent with previous reports showing that alterations in RNA
decay rates do not seem to provide a major contribution during
the first 3 h of the response of fibroblasts to type I and II
interferons [34] or of dendritic cells to lipopolysaccharides [41]. It
is important to note that the high MOI we employed facilitated the
initiation of a fast, contemporaneous infection, crucial to dissect
the temporal cascade of rapid transcriptional changes during lytic
MCMV infection. This approach revealed extensive regulation,
which remained undetectable in total cellular RNA. These
elements of the host response to lytic infection are of particular
interest because they are likely to be subjected to rapid viral
counter-regulation. Analysis of newly transcribed RNA combined
with the use of UV-inactivated virus detailed such rapid viral
counter-regulation for inflammatory-, interferon-, DNA-damage-
and ER-stress-induced changes. While numerous MCMV proteins
have been shown to counteract the consequences of the induced
ER-stress response, i.e. the induction of stress-induced natural
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Figure 6. Analysis of MCMV gene expression by RNA-seq. Shown are the coverages of all viral genes across the MCMV genome obtained by
RNA-seq on newly transcribed RNA from uninfected cells, 1–2 hpi, 5–6 hpi, 11–12 hpi, 18–19 hpi, 24–25 hpi and 47–48 hpi, normalized to the total
number of reads mapped to mouse exons and annotated MCMV coding sequences. Genomic positions of exemplary genes as well as concordantly
regulated gene clusters are marked; SCP= small capsid protein (m48.2), POL=polymerase (M54). Blue represents transcripts matching the direct DNA
strand and red the complementary DNA strand.
doi:10.1371/journal.ppat.1002908.g006
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killer cell activating ligands (reviewed in [83]), little is known about
the counter-regulation of ER-stress signaling itself. The same is
true for the very transient DNA-damage response we observed.
The rapid counter-regulation in transcriptional activity revealed
by newly transcribed RNA implies the existence of novel viral
factors targeting these important cellular processes. Furthermore,
our approach will now allow screening of large deletion mutants
for the responsible viral genes.
Analysis of newly transcribed RNA revealed delayed down-
regulation of genes involved in chromatin modification as well as
down-regulation of genes involved in cell proliferation and actin
filament-based processes. Within a few hours of infection,
MCMV-infected cells show a profound cytopathic effect. The
underlying molecular events remain to be elucidated. It is
tempting to speculate that transcriptional down-regulation of
genes involved in actin filament-based processes and cell adhesion,
which we found to be consistently down-regulated as early as 1–2
hpi, contributes to this phenomenon.
As we exemplified for both NF-kB and c-Myc, changes in
transcriptional activity (as detectable in newly transcribed RNA)
directly mirror the changes in the activation status of the involved
transcription factors. In addition, the ability to group the large
number of differentially regulated genes (as usually identified when
analyzing total RNA changes) into well-defined functional clusters
of genes (regulated with distinct kinetics) further aids the
subsequent success of in silico promoter analyses. Our approach
thus provides an ideal mean to obtain insights into the molecular
mechanisms/transcription factors involved. It is important to note
that most of the transcription factors, implicated by our promoter
analysis, have already been associated with the functional
annotations of the respective gene clusters. In addition, many of
the transcription factors specifically over-represented in the
clusters (see Table S2b) were consistent with published data on
their functional role in lytic CMV infection.
Of interest, E2F-sites were significantly over-represented in
genes repressed with delayed kinetics (Cluster 5). The E2F family
consists of both activating and repressing transcription factors (for
review see [84,85]). The activating E2F family members, E2F-1, -2
and -3, are important for the transactivation of target genes
involved in G1/S transition and apoptosis. E2F-4 and -5
predominantly have repressive functions, mediating cell-cycle exit
and cell differentiation. E2F-6, -7 and -8 also act as transcriptional
repressors, but are less well characterized. A caveat of this is that
the DNA-binding sites of the E2F-family members cannot be
differentiated from each other by bioinformatics means, highlight-
ing the complexity of this regulation. Therefore, the repression of
genes in Cluster 5 could either be mediated by repression of
activating E2F-family members (E2F-1,-2 and -3) or activation of
repressive family members like E2F-4 and -5. Interestingly, the
most significantly associated gene ontology for Cluster 5 was not
‘G1/S-phase of the mitotic cell cycle’, as would have been
expected in case of E2F-1-associated regulation, but ‘M-phase of
the mitotic cell cycle’. Recently, the LIN complex (LINC), which
involves the repressive E2F-4 family member, was shown to
selectively repress genes involved in G2/M phase [86]. A closer
look at the genes of Cluster 5 revealed the presence of numerous
genes reported by this and other work [87] to be key marker-genes
repressed by the LINC complex (which involves E2F-4). These
included Survivin (Birc5), Cyclin B1, Aurkb, Espl1 and Bub1. It is
thus tempting to speculate that the repression of genes in Cluster 5
is mediated not by repression of activating E2F-family members,
but by activation of repressive E2F-family members (involving
LINC). Ongoing work seeks to clarify the role of E2F-family
members in this regulation. Lytic HCMV infection has been
shown to result in E2F-1 activation by rapid degradation of the
under-phosphorylated form of pRB by the HCMV protein pp71
[88,89] and to increase E2F-1 responsive genes [64]. Of note, we
did not observe over-representation of E2F sites in any of the
MCMV-induced gene clusters. While HCMV can only induce
lytic infection in G0/G1 phase, MCMV can also efficiently
replicate in cells that have passed through S phase by arresting
them in G2 [90]. Differences in shifting cell populations may thus
account for the lack of E2F-1 over-representation in our MCMV-
induced gene clusters.
4sU-tagging provides the unique opportunity to study the
regulation of viral gene expression in real-time without the
interference of virion-associated RNAs. Employing 4sU-tagging
combined with qRT-PCR and RNA-seq to lytic MCMV infection,
we report on three surprising findings. 1) A peak of viral gene
expression including expression of immediate-early, early and even
well-characterized late genes at 1–2 hpi at both high and low
MOI. 2) The rapid suppression of all three classes of viral gene
expression by 5–6 hpi. 3) Very constant levels of viral gene
transcription rates (e.g. for ie1 and m169) or even continuously
increasing suppression (e.g. m152), despite the onset of extensive
viral DNA replication.
Both qRT-PCR and RNA-seq on newly transcribed RNA
revealed a peak of transcriptional activity of viral genes at 1–2 h of
lytic MCMV infection, to an extent only reached again at late
stages of infection (47–48 hpi). We were surprised to observe that
this even included transcription of well-characterized late genes,
e.g. m129–131 and M94. Rigorous controls excluded DNA
contamination, virion-associated RNA and gene expression from
the opposing DNA strand. Furthermore, this transcriptional
activity was also observed at low MOI. In this case, however,
the peak of both early (m152 and m169) and late (M94 and m129/
131) gene expression slightly shifted from 1–2 hpi to 3–4 hpi, thus
separating this from the peak of immediate-early gene expression,
which still had already peaked at 1–2 hpi. Although even our low
MOI infection will still have resulted in multiple virus particles
entering the cells, this shift strongly argues against ‘leaky’
promoters being responsible for this late gene expression. It rather
highlights a role of virus-mediated regulation (most likely mediated
by IE- or viral tegument-proteins) in facilitating this part of viral
gene expression. It is important to note that this early burst in ‘late’
transcripts at 1–2 hpi does not generate defective or partially
processed transcripts. Transcripts were both poly-adenylated
(cDNA synthesis for qRT-PCR was performed with oligo-dT
primers) and fully spliced (m129-m131). Nevertheless, it is still
unclear whether the respective transcripts are actually translated.
Recent reports indicate regulation occurring at the level of
translation to provide a major contribution to overall regulation of
mammalian gene expression [42]. It is tempting to speculate that
the virus uses additional, so far undisclosed mechanisms, to
regulate its gene expression at post-transcriptional level. Of note,
previous studies already postulated a role of post-transcriptional
regulation in HCMV [91] and expression of some HCMV genes
has already been shown to be regulated at post-transcriptional
level [92,93].
Interestingly, the peak of viral gene expression we observed at
1–2 hpi was followed by a rapid drop in transcription rates by 6–
12 hpi. We were surprised to see this rapid down-regulation of
early gene expression. Interestingly, this was sustained or even
exaggerated at late times of infection. What is the cause of this
down-regulation? Chromatin modifications of the viral genome
are well known to play an important role during productive CMV
infection (reviewed in [94]). The ND10 body-associated protein
Daxx is known to rapidly repress transcription of incoming viral
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genomes by inducing repressive chromatin modifications around
the HCMV major immediate-early promoter (MIEP) within 3 hpi.
Dependent on the MOI of infection, the virus is able to overcome
this repression. This results in the inhibition/reversion of HDAC-
mediated repression of the viral genomes present in the nucleus
and initiates the expression of early genes [21,95]. It is important
to note that the peak of early gene expression should thus only
occur after ND10 body-mediated repression has already been
efficiently disrupted. Our data is fully consistent with this
hypothesis. While we observed both immediate-early and early
gene expression to peak or already have peaked at 1–2 hpi
following high MOI (consistent with rapid disruption of ND-10
bodies), low MOI resulted in a visible delay between the peak of
immediate-early and early gene expression. This is consistent with
a delayed dispersion of ND-10 body-mediated repression of early
gene expression at low MOI. Of note, we observed repression of
viral gene expression after the peak of early gene expression, i.e.
after ND-10 bodies have already been dispersed. Therefore, this
suppression, which we observed by both qRT-PCR and RNA-seq
to occur in between 6 and 12 hpi, is unlikely to be due to the
intrinsic antiviral defense known to be mediated by ND-10 bodies.
Interestingly, transcription of some genes, e.g. ie1 and m169
substantially dropped and then continued at low level despite the
onset of viral DNA replication (i.e. a rapid .100-fold increase in
viral DNA load). The most likely explanation for this observation
is that the DNA architecture of de novo synthesized viral genomes
does not support transcription of (at least) some viral genes. On the
other hand, it is tempting to speculate that these differences in
chromatin structure play an important role in initiating viral late
gene expression. Interestingly, transcription rates of some viral
genes, e.g. m152, continued to drop (exceeding 500-fold compared
to 1–2 hpi) until 47–48 hpi. These observations highlight the
importance of transcription factors in the regulation of viral gene
expression. It is tempting to speculate that the early burst of
transcriptional activity is due to activation of specific cellular
transcription factors, which are transiently activated following
virus entry but can only initiate viral gene expression (but for the
IE genes) once ND-10 body-mediated repression has been
overcome. Most likely, their subsequent de-activation by 5–6 hpi
is responsible for the subsequent drop in transcription of viral
genes we observed. It may result from cellular or viral
mechanisms. With the onset of viral DNA replication these or
other transcription factors are again activated culminating in viral
late gene expression. Activation and repression of these transcrip-
tion factors will also influence the expression of the cellular genes
they govern. The kinetics of viral gene expression during the first
few hours of infection best matches those of cellular genes within
the Clusters 1 and 2. This is consistent with the well described
presence of binding sites for NF-kB and even interferon stimulated
response elements (ISRE) in many viral promoters [96,97]. The
changes in transcription factor activity following the advent of viral
DNA replication are less well understood. 4sU-tagging now allows
us to properly study the changes in cellular gene expression
following the onset of viral DNA replication. Correlating these
with the changes in viral gene expression will substantially enhance
our understanding of how these viruses modulate the host-cell
machinery for their own needs and pinpoint novel targets for
antiviral intervention.
Materials and Methods
Cell culture and virus infection
Murine NIH-3T3 fibroblasts were cultured in DMEM (Gibco)
supplemented with 5% fetal calf serum. Cells were seeded
overnight to 80% confluence followed by infection with BAC-
derived MCMV Smith strain. Infection was performed at an MOI
of 10 using centrifugal enhancement (30 min, 2000 rpm) or an
MOI of 0.5. The time point after centrifugation was marked as
time point ‘0 min’ in all experiments. To block RNA polymerase
II transcription, Actinomycin-D (Sigma) was used at a final
concentration of 5 mg/ml. UV irradiation of virus stocks was
performed with 1500 J/m2 UV light using a UV-Crosslinker
(Vilber Loumart). Standard plaque assays were performed as
described [98] to analyze the influence of 4sU on productive virus
infection and to confirm the efficiency of UV-inactivation.
Metabolic labeling and purification of newly transcribed
RNA
RNA labeling was started by adding 200 mM 4-thiouridine
(4sU, Sigma) to cell culture media for 1 h at different times of
infection. At the end of labeling, total cellular RNA was isolated
using Trizol reagent (Invitrogen). Biotinylation and purification of
4sU-tagged RNA (newly transcribed RNA) as well as dot blot
analysis were performed as described previously [34]. For all
samples subjected to qRT-PCR analysis, DNase I (Fermentas)
treatment was performed on total RNA according to the
manufacturer’s instructions before biotinylation. RNA was recov-
ered using the RNeasy Mini Kit (Qiagen).
Reverse transcription and quantitative PCR
Reverse transcription was carried out in 20 ml reactions using
Superscript III (Invitrogen) and Oligo-dT primers (Invitrogen)
following the manufacturer’s instruction. Samples were diluted 1:5
with H2O before performing qRT-PCRs on a Light Cycler (Roche
Molecular Biochemicals) as described in Do¨lken et al. [34].
Relative quantification was performed in relation to uninfected
controls normalized to the housekeeping gene Lbr (Lamin B
receptor). Primers were designed using the online Roche Universal
Probe Library primer design tool spanning exon-exon junctions.
All primers are listed in Table S3.
Microarray analysis, data processing and statistical
analysis
For the microarray analysis, 200 ng RNA of each sample was
amplified and labeled using the Affymetrix Whole-Transcript
(WT) Sense Target Labeling Protocol without rRNA reduction.
Affymetrix GeneChip Mouse Gene 1.0 ST arrays were hybridized,
washed, stained, and scanned according to the protocol described
in WT Sense Target Labeling Assay Manual. Microarray data
were assessed for quality and normalized with RMA. All
microarray data are available at Gene Expression Omnibus
(GEO) record GSE35919.
Quality control, normalization, filtering, statistical testing
Data were analyzed using R and Bioconductor [99]. Only
’’present‘‘ genes (i.e. expression values greater than 20 in at least 2
out of the total number of arrays for each RNA type) were
included in downstream analysis. In the total RNA data set,
n = 9,022 genes passed this filter; in the newly transcribed RNA
data set, n = 9,399 genes passed. To better compare fold-changes
between the total and newly transcribed data, the set union of
genes (n = 10,071) was used. Differentially expressed genes were
identified separately for the total RNA and newly transcribed
RNA data sets using the LIMMA package. Differential expression
was defined as having an estimated fold-change of at least 2
(calculated as the fold-change of the average expression in the
triplicate measurements after infection compared to uninfected
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status) and a p-value smaller than 0.05 (adjusted for multiple
testing using the Benjamini and Hochberg method [100]).
Grouping of differentially expressed genes into co-
regulatory modules and functional annotations
Newly transcribed transcripts, which showed differential
expression in at least one condition, were grouped into clusters
based on their fold-changes in newly transcribed RNA upon
MCMV infection. Five clusters were defined (for gene lists see
Table S1c). Briefly, cluster 1 contains rapidly induced genes (.2-
fold at 1–2 hpi) which are .2-fold counter-regulated by 3–4 hpi.
Cluster 2 comprises genes induced with slightly delayed kinetics
(,2-fold induction at 1–2 hpi, but .2-fold at 3–4 hpi) showing
.2-fold counter-regulation by 5–6 hpi. Cluster 3 comprised genes
which were not induced at 1–2 hpi (,1.41-fold induced= 20.5) but
.2-fold induced by 5–6 hpi and not counter-regulated .2-fold by
5–6 hpi. Consistently down-regulated genes (.2-fold at 1–2, 3–4
and 5–6 hpi, with ,1.41-fold variation in the extent of repression
in between 1–2 and 5–6 hpi) define cluster 4. Finally, Cluster 5
comprises all genes not repressed .1.41-fold at 1–2 hpi but
repressed .2.82-fold (21.5) at 5–6 hpi. It is important to note that
the criteria and cut-offs for these cluster were chosen empirically
trying to keep the criteria simple. This resulted in cluster
containing 50–100 genes thus providing solid templates for the
down-stream bioinformatic analyses. Enrichment analysis of Gene
Ontology ‘Biological Process’ terms and KEGG pathways was
performed for each cluster using the DAVID bioinformatics
analysis suite (http://david.abcc.ncifcrf.gov/; release 6.7) [101].
Identification of over-represented transcription factor
binding sites (TFBSs) in promoter regions
For all probe sets with a mapped EnsEMBL ID, the core
promoter sequence (2500 to +100 bp relative to the transcrip-
tional start site (TSS)) was retrieved using the Regulatory
Sequence Analysis Tools (RSAT; http://rsat.ulb.ac.be/) retrieve
EnsEMBL seq function. In case of alternative transcripts the most
59 TSS was chosen. Over-represented TFBSs for each cluster were
predicted using Transcription Factor Matrix (TFM) Explorer
(http://bioinfo.lifl.fr/TFM/TFME/; release 2.0) [102]. Weight
matrices modeling putative TFBSs were taken from TRANSFAC
(version 6.0 public; vertebrate matrices only). P-value thresholds to
define locally over-represented TFBSs were set to 0.0001 and
0.00001 for clusters of less or more than 100 genes, respectively.
Immunoblotting and immunofluorescence
For immunoblotting, NIH-3T3 infected with MCMV were
harvested in 500 ml cell lysis buffer (62.5 mM Tris, 2% SDS, 10%
glycerol, 6 M urea, 5% b-mercaptoethanol, 0.01% bromophenol
blue, 0.01% phenol red) at several time points of infection.
Following heat denaturation (95uC, 5 min), 50 ml of the lysates
were subjected to SDS-PAGE. Proteins were transferred to a
nitrocellulose membrane (Schleicher & Schuell) using a semidry
blotter (Peq-Lab) (2 h, 400 mA). Membranes were blocked in PBS
+2.5% milk powder and subsequently incubated with primary
antibody (o/n, 4uC). After incubation with horseradish peroxidase-
conjugated secondary antibody (1 h, RT) the proteins were
visualized by the ECL system (Perkin Elmer) in the Fusion FX
device (Vilber Lourmat).
For indirect immunofluorescence NIH-3T3 cells were seeded
onto fibronectin-coated glass cover-slips in 24-well plates and
infected with MCMV. At various time points of infection, cells
were fixed with 4% paraformaldehyde in DPBS (w/v) for 10 min
at 37uC. The fixative solution was replenished twice with DPBS
and the cells were permeabilized for 10 minutes with a solution of
0.1% Triton X-100 in DPBS. After extensive washing with DPBS,
the cells were blocked using 3% (w/v) BSA in DPBS (blocking
solution) for 1 h at room temperature (RT). Primary antibodies
were applied in blocking solution and incubated with the cells at
RT for 1 h followed by three DPBS washing steps and 1 h
incubation at RT with 1:1,000 dilutions of Alexa Fluor-conjugat-
ed, specific secondary antibodies (Invitrogen) in blocking solution.
After a final washing step with DPBS, the preparations were
mounted on glass slides with Prolong Gold including DAPI
(Invitrogen) and analyzed using an LSM 710 (Zeiss) confocal laser
scanning microscope with 405 nm, 488 nm and 561 nm laser
excitation and appropriate filter sets.
The following primary antibodies were used for immunoblot-
ting and -fluorescence: mouse anti-IE1 (CROMA101; kindly
provided by S. Jonijic, University of Rijeka, Rijeka, Croatia),
rabbit anti-GAPDH (mAbcam 9484) from Abcam, rabbit anti-
RelA (A) and mouse anti-IkB-a (H4) from Santa Cruz Biotech-
nology.
Luciferase assays
To monitor the activity of c-Myc-regulated signal transduction
pathway, cells were transfected in a 6-well format using the Cignal
c-Myc-Reporter (luc) Kit from Qiagen. 6 hours post transfection
cells were seeded in 96-well plates (10,000 cells/well). 48 hours
after seeding, the transfected cells were infected with MCMV
(n= 3). At various times of infection, cells were lysed in 100 ml lysis
buffer and luciferase firefly activity was determined according to
the manufacturer’s (Promega) instructions.
Next Generation Sequencing
RNA was subjected to WTAK library construction to generate
transcriptomic fragment libraries (50 bp, SOLiD (Life Technolo-
gies, Foster City, CA, USA) Total RNA-seq Kit V3) that preserve
strandedness information of the reads. Molecular barcoding was
used in order to pool several libraries in a single sequencing
reaction according to the manunfacturer’s protocol. Sequencing
was performed using the SOLiD 3 system (Life Technologies).
Potential sequencing errors were corrected using the SOLiD
Accuracy Enhancement Tool (solidsoftwaretools.com/gt/project/
saet). All sequencing data are available at Gene Expression
Omnibus (GEO) at GSE35833.
Short-read alignment, MCMV read coverage
Between 26 and 42 million 50 nt reads were obtained per
sample (Table S4a). Reads were aligned in a 4-step process using
the Bowtie alignment program. First, all reads were aligned to
mouse transcripts (Ensembl version 63). Remaining unaligned
reads were aligned to the mouse genome (mm9, NCBI Build 37).
Remaining reads were aligned to MCMV coding sequences and
finally to the full MCMV genomic sequence. Reads with
ambiguous base calls, non-unique alignment positions or more
than 4 mismatches were discarded. Reads were classified as exon-
exon and exon-intron junction reads, respectively, if they
overlapped an exon-exon or an exon-intron junction by $1 nt
(Table S4a). MCMV genome coverage was scaled before plotting
(for Figure 6 and S7). Scaling factors were derived using DESeq
based on reads aligned to mouse exons. RPKM values of
individual MCMV genes are included in Table S4b).
Supporting Information
Figure S1 No effect of 1 h 200 mM 4sU treatment on
virus replication. NIH-3T3 fibroblasts were infected with
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MCMV at an MOI of 10 for 48 h. Samples were exposed to
200 mM 4sU for 1 h at different time points of infection or left
untreated. Supernatants were harvested and titrated at 48 hpi.
Shown are the means +/2 SD of three biological replicates.
(TIF)
Figure S2 Cluster of all differentially regulated genes in
newly transcribed RNA. Heat-map indicating fold-changes
with rows representing genes and columns representing time
points post infection. Red represents up-regulation, blue down-
regulation (.2-fold, p#0.05) in newly transcribed RNA relative to
uninfected cells. Ordering of genes was determined using non-
supervised hierarchical clustering across two conditions: regulation
at 3–4 hpi minus 1–2 hpi and regulation at 5–6 hpi minus 1–2 hpi
(using log2-values of fold-changes compared to uninfected cells).
Clustering was performed separately for induced and repressed
genes. Gray scales depicted on the left mark genes belonging to the
corresponding clusters described in Figure 2A.
(TIF)
Figure S3 Temporal kinetics of MCMV replication.
NIH-3T3 cells were infected with MCMV at an MOI of 10 and
DNA was isolated at various times of infection using the DNeasy
Blood & Tissue Kit (Qiagen) according to the manufacturer’s
instructions. Prior to amplification, extracted DNA was digested
with PaeI for 1 h, 37uC followed by heat inactivation. (A) TaqMan
qRT-PCR was performed in triplicates for MCMV M54 and
cellular Lbr using the ABI Prism 7700 sequence detector (Applied
Biosystems) as described [103]. Synthesis rates were normalized to
Lbr. Shown are the means +/2 SD of three independent
experiments. (B) Southern Blot analysis was performed as
described in Popa et al. [104]. Shown is the detection of different
genome fragments in DNA isolated from NIH-3T3 cells at various
times of infection. MCMV BAC-DNA (BAC) served as a negative
control. The 3 kb fragment serves as a measurement of genomic
load, the 2 kb fragment for concatameric/circular DNA and the
1 kb fragment for cleaved genomic DNA. Due to its circular form,
digested BAC DNA produces only two of the three fragments.
(TIF)
Figure S4 Gene expression kinetics of exemplary viral
genes in total RNA. Shown are qRT-PCR measurements on
total RNA for ie1 (A), the early genes m152 (B) and m169 (C) as
well as for the late genes m129/131 (D) and M94 (E). Total RNA
rates were normalized to Lbr expression. Shown are the combined
data (means +/2 SD) of three independent experiments.
(TIF)
Figure S5 Regulation of viral gene expression following
low and high MOI. NIH-3T3 cells were infected with (A) an
MOI of 0.5 (low MOI) and (B) an MOI of 10 (high MOI, data
taken from Figure 5B–F). Newly transcribed RNA was labeled
from 21 to 0 (mock), 1–2, 3–4 and 5–6 hpi. Following purification
of newly transcribed RNA, expression levels of ie1, m152, m169,
m129/131 and M94 were determined by qRT-PCR normalized
for Lbr.
(TIF)
Figure S6 Classification of reads aligned to mouse
transcripts and genomic sequence. Reads were classified
according to their alignment position in mouse transcripts or
genomic sequence as exon, intron, exon-exon junction, or exon-
intron junction reads. Shown are the relative frequencies of each
class for total, pre-existing, and newly transcribed RNA samples
derived from NIH-3T3 cells at various times of infection. The high
fraction of intronic reads in newly transcribed RNA samples is
consistent with the increased proportion of premature transcripts
present in newly transcribed RNA.
(TIF)
Figure S7 RNA-seq data on MCMV gene expression
using total RNA and unlabeled pre-existing RNA. Shown
are the read coverages of all viral genes across the whole MCMV
genome obtained by RNA-seq for uninfected cells for (A) newly
transcribed RNA samples and 25 hpi and 48 hpi for (B) total RNA
samples and (C) pre-existing RNA samples normalized to the total
number of mapped exonic mouse reads. Positions of exemplary
genes as well as representative gene clusters showing concordant
regulation are indicated; SCP= small capsid protein (m48.2),
POL=polymerase (M54). Blue represent reads matching to the
direct DNA strand and red represents reads matching to the
complementary DNA strand.
(TIF)
Table S1 A. List of MCMV-regulated cellular genes. This
table contains all (n = 1,674) cellular genes significantly (p,0.05)
regulated by .2-fold in at least one condition (total or newly
transcribed RNA) during the first six hours of MCMV infection
compared to uninfected NIH-3T3 cells. Log2 values of detected
fold-changes are depicted. Positive values represent up-regulation,
negative represent down-regulation. B. List of MCMV-regu-
lated genes with greater change in total RNA than in
newly transcribed RNA. This table contains all genes which
showed at least 1.41-fold (20.5) greater regulation in total RNA
than in newly transcribed RNA at any time point of infection (0–6
hpi). Log2 values of the fold-changes compared to uninfected cells
are shown. Only three genes (Mela, Tk1 and Plk1, indicated in
yellow) showed .2-fold stronger regulation in total RNA than in
newly transcribe RNA, arguing against a significant contribution
of changes in RNA decay rates contributing to the observed
changes. C. Clusters of genes regulated with distinct
kinetics. Genes significantly regulated during the first 6 hours of
lytic MCMV infection were grouped into clusters showing distinct
kinetics of regulation. Genes belonging to the five clusters we
identified are shown. Log2 values of changes compared to mock
are depicted. Positive values represent up-regulation, negative
represent down-regulation. Below each cluster, the filters applied
are shown highlighted in red.
(XLSX)
Table S2 Bioinformatic analysis on MCMV-regulated
gene clusters. A. Enrichment analysis of Gene Ontology
‘Biological Process’ terms and KEGG pathways. Results
of the Gene Ontology (GO) (‘Biological Process’ only) and KEGG
pathway enrichment analysis. For significantly enriched annota-
tion categories (p-value,0.01) the count (i.e. number of genes
involved in the term), percentage (involved genes/total genes), and
a modified Fisher Exact p-value are given. Moreover, genes
annotated to each category are listed with their Affymetrix
identifiers. B. TFM Explorer results Over-represented tran-
scription factor binding sites (TFBSs) for each cluster were
predicted using Transcription Factor Matrix (TFM) Explorer.
See methods for scanning parameters. Identified TFBSs are given
with their rank (most significant first); matrix name; transcription
factor name; information of content of the matrix; gc content of
the matrix (G+C)%; location of the identified binding sites
(relatively to TSS); and p-value. For each identified TFBS the
entire list of hits in all input sequences is also given. Information
includes gene name; location (position and strand orientation) of
binding motif; matrix similarity; and motif instance.
(XLSX)
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Table S3 List of PCR Primers. All PCR primers used in this
study are listed.
(XLSX)
Table S4 Analysis of RNA-seq data. A. Statistics of RNA-
seq data. Number of reads from MCMV infected NIH-3T3 cells
aligned to the cellular and viral genome. Shown are (I) the number
of reads per sample, (II,III) intron, exon and junction reads of
cellular (II) and viral genes (III). B. RPKM values of viral
transcripts. For all MCMV genes reads mapped to the
annotated coding sequences of Smith strain MCMV were used
for RPKM calculation. Normalization for sample size was done
using the total number of reads mapped to exons or exon-exon
junctions in mouse or virus. RPKM values are rounded.
(XLSX)
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